QG
Qiagen
QGEN · NYSE
$43.46 -0.92% (-$0.41)
1M -0.87%
Market Cap $8.96B
P/E Ratio 21.90x
Div. Yield 0.81%
ROE 11.60%
Bulios Fair Price
$25.19
42.0% downside
Trenutna cena
$43.46
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica QGEN trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
7/9Valuation
62 /100
Fair P/E 21.90x
P/FCF 20.02x
EV/EBITDA 13.36x
Growth
17 /100
Declining EPS growth 0.16%
Book val. growth 2.91%
Rev. growth 0.81%
Profitability
100 /100
Strong Gross margin 61.82%
FCF margin 21.32%
Net margin 19.49%
Quality
50 /100
Average ROIC 8.86%
Asset turnover 0.36x
ROE 11.60%
Debt
89 /100
Low Debt/Equity 0.49x
Net debt/EBITDA 1.19x
Current ratio 2.85x
Stability
70 /100
Stable Beta 0.63x
Profitable years 6
Rev. volatility 7.03%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o QGEN
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Thierry L. Bernard
Employees
5,500
Headquarters
Venlo
Prihajajoči dogodki
03 NOV.
Earnings
Upcoming earnings report